Journal profile · Respiratory System
Respiratory Medicine
ISSN 0954-6111 · eISSN 1532-3064 · W.B. Saunders Ltd · ENGLAND · Monthly · Founded 1989
Respiratory Medicine: CAS Zone 3 · Medicine (2025 upgraded edition); impact factor 3.28; hybrid open access; APC about USD 3,630; median 128 days to acceptance (117 articles, last 24 months); community-reported acceptance: about 25%; 592 articles in 2025; indexed in SCIE and Scopus.
Scope
Aims, scope and focus
Respiratory Medicine is published by W.B. Saunders Ltd and is in Zone 3 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Chronic Obstructive Pulmonary Disease (COPD) Research, Asthma and respiratory diseases and Respiratory and Cough-Related Research, together about 43.1% of its articles. Its main subfields are Pulmonary and Respiratory Medicine. (generated from OpenAlex topic counts and CAS ranking data)
Respiratory Medicine is an international, peer-reviewed journal dedicated to advancing the understanding, diagnosis, and management of respiratory diseases. Its mission is to publish high-quality original research, comprehensive reviews, and clinically relevant studies that contribute to improving care for patients with both acute and chronic respiratory disorders.Scope of the journal includes (but is not limited to):Chronic obstructive pulmonary disease (COPD), asthma, bronchiectasis, and interstitial lung diseasesPulmonary infections, tuberculosis, and emerging respiratory pathogensSleep-related breathing disorders and sleep medicineRespiratory failure, critical care, and mechanical ventilationLung cancer and thoracic oncologyTranslational research on respiratory pathophysiology, immunology, and inflammationEnvironmental and occupational lung diseases, smoking-related injury, and air pollution effectsAdvances in diagnostic imaging, pulmonary function testing, and biomarkersNovel therapeutics, drug delivery systems, and interventional pulmonologyEpidemiology, health economics, and public health aspects of respiratory careThe journal welcomes submissions from clinicians, researchers, and allied health professionals working in respiratory and related disciplines. Please note: Review submissions must be pre-approved prior to submission. Please email Prof. Cazzola at mario.cazzola@uniroma2.it to request pre‑submission approval. Respiratory Medicine strives to foster evidence-based advances and international collaboration, ultimately supporting the improvement of respiratory health at a population level.
From the journal's Aims & Scope
Research area (LetPub): Respiratory System
Editor-in-chief Nicola A. HananiaPublisher website
Editorial board by country: 2 in mainland China (about 2%); most named United States 48, Italy 13, United Kingdom 6, Netherlands 5, Sweden 5 (106 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- Chronic Obstructive Pulmonary Disease (COPD) ResearchMedicine19.1%
- Asthma and respiratory diseasesMedicine17%
- Respiratory and Cough-Related ResearchMedicine7%
- Respiratory Support and MechanismsMedicine6.7%
- Interstitial Lung Diseases and Idiopathic Pulmonary FibrosisMedicine6%
- Inhalation and Respiratory Drug DeliveryMedicine5.8%
- Delphi Technique in ResearchSocial Sciences3.9%
- Cystic Fibrosis Research AdvancesMedicine3.1%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 3 |
| Minor | Cardiac & Cardiovascular Systems | Zone 3 |
| Minor | Respiratory System | Zone 3 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 3 |
| Minor | Cardiac & Cardiovascular Systems | Zone 3 |
| Minor | Respiratory System | Zone 3 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 3 |
| Minor | Cardiac & Cardiovascular Systems | Zone 3 |
| Minor | Respiratory System | Zone 3 |
Top journal: noReview journal: no
Database indexing
SCIEScopusLetPub
International journal early-warning lists: not listed in any editionLetPub
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 3.28LetPub ·
- Impact factor (publisher)
- 3.3Publisher website ·
- CiteScore 2026-06
- 4.3LetPub ·
- CiteScore (publisher)
- 4.3Publisher website ·
- SJR 2026-06
- 0.98LetPub ·
- SNIP 2026-06
- 1.13LetPub ·
- h-index
- 108LetPub ·
- h-index
- 175OpenAlex ·
- i10-index
- 5,947OpenAlex ·
- 2-year mean citedness
- 2.34OpenAlex ·
- Self-citation rate
- 3%LetPub ·
- Share of gold OA articles
- 28.79%LetPub ·
Volume
- Articles per year
- 531LetPub ·
Articles by year OpenAlex count · 10,490 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 476 | 180 | 139 |
| 2025 | 592 | 249 | 1,378 |
| 2024 | 317 | 168 | 1,729 |
| 2023 | 267 | 264 | 2,904 |
| 2022 | 219 | 219 | 3,028 |
| 2021 | 348 | 303 | 6,596 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with PubMed · to
128 daysMedian, submission to acceptance · P25–P75 91 days – 171 days
- Acceptance to online
- median 2 days (117 articles)
- Submission to online
- median 132 days
- Sample
- 117 articles with submission and acceptance dates (1,176 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- about 3 monthsLetPub ·
- Average acceptance (community reports)
- 25%LetPub ·
- Submission to first decision
- 17 daysPublisher website ·
- First decision after review
- 65 daysPublisher website ·
- Submission to acceptance
- 113 daysPublisher website ·
- Acceptance to publication
- 2 daysPublisher website ·
- Peer review
- Single-anonymous peer review, at least 2 reviewersPublisher website · model-extracted
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Hybrid open accessLetPub
A subscription journal in which authors can pay to publish their article open access.
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| OpenAlex | USD 3,630 / EUR 3,400 / GBP 2,910 / JPY 450,230 | — | — | |
| Publisher website | USD 3,240 | — | — |
A hybrid journal charges the APC only when the author chooses open access; publishing under the subscription model is usually free.
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
Open calls for papers1, by deadline
Publisher websiteWhat to prepare4 items from the author guidelines
- Abstract
- ≤ 250 words
- Keywords
- 1–7
- Manuscript length
- ≤ 4,500 words
- Reference style
- Numbered, in order of citation
Article types accepted12, with length limits
- clinical trial protocols6. Clinical Trial ProtocolsLength not stated
- correspondence5. CorrespondenceLength not stated
- invited narrative reviews3. Invited Narrative ReviewsLength not stated
- letterflexible with justification 4. Research Letters Word count: ≤ 1,200 words Figures/Tables: ≤ 3 References: ≤ 15 5. Correspondence Wordmain text ≤ 1,200 words
- meta-analysis1. Original Research Articles Word count: ≤ 3,500 wordsFigures/Tables: up to 8 combinedReferences: up to 75 (extendable to 100 with justification)Notes: Encoura…Length not stated
- narrative review1. Original Research Articles Word count: ≤ 3,500 wordsFigures/Tables: up to 8 combinedReferences: up to 75 (extendable to 100 with justification)Notes: Encoura…main text ≤ 4,500 words
- original research article1. Original Research Articles Word count: ≤ 3,500 wordsFigures/Tables: up to 8 combinedReferences: up to 75 (extendable to 100 with justification)Notes: Encoura…main text ≤ 3,500 words
- original research articles1. Original Research Articles Word count: ≤ 3,500 wordsLength not stated
- protocol1. Original Research Articles Word count: ≤ 3,500 wordsFigures/Tables: up to 8 combinedReferences: up to 75 (extendable to 100 with justification)Notes: Encoura…main text ≤ 3,500 words
- research letters4. Research LettersLength not stated
- systematic review1. Original Research Articles Word count: ≤ 3,500 wordsFigures/Tables: up to 8 combinedReferences: up to 75 (extendable to 100 with justification)Notes: Encoura…main text ≤ 4,500 words
- systematic reviews & meta-analyses2. Systematic Reviews & Meta-Analyses (including Invited Narrative Reviews)Length not stated
Policy excerpts from the journal's websiteAI use, Authorship, Conflicts of interest, License & copyright, Open access, Peer review, Preprints
- AI use Declaration of generative AI use
Authors must declare the use of generative AI tools in the manuscript preparation process upon submission of the paper.Generative AI and AI-assisted technologies (“AI tools”) have been rapidly adopted in research and scholarly publishing, offering significant benefits while requiring clear standards for responsible and transparent use.Authors preparing a manuscript for this journal may use AI tool…
Source ↗Publisher website ·- Authorship Group authorship
Group authorship refers to the attribution of an article to a defined and named group of authors whose members have contributed to the work. Examples include research consortia, clinical trial groups, collaborative networks, task forces or working groups, expert panels or consensus groups, and participatory research groups. Group authorship must be declared on the title page at submission. When av…
Source ↗Publisher website ·- Conflicts of interest Declaration of competing interests
All authors must disclose any financial and personal relationships with other people or organizations that could inappropriately influence or bias their work. Examples of potential competing interests include:EmploymentConsultanciesStock ownershipHonorariaPaid expert testimonyPatent applications or registrationsGrants or any other fundingAffiliation with the journal as an Editor or Advisory Board …
Source ↗Publisher website ·- License & copyright License options
Authors will be offered open access user license options which will determine how you, and third parties, can reuse your open access article. We advise that you review these options and any funding body license requirements before selecting a license option.
Source ↗Publisher website ·- Open access Open access
We refer you to our open access information page to learn about open access options for this journal.
Source ↗Publisher website ·- Peer review Peer review
Single anonymized peer review; minimum two reviewers; editors make final decision. Model summary
This journal follows a single anonymized review process. Your submission will initially be assessed by our editors. If your submission is deemed suitable, it will typically be sent to be reviewed by a minimum of two reviewers for an independent expert assessment of the scientific quality. The decision as to whether your article is accepted or rejected for publication will be made by our editors.Re…
Source ↗Publisher website ·- Preprints Preprints
Review submissions require pre-approval via email to Prof. Cazzola. Model summary
Preprint sharingAuthors may share preprints in line with Elsevier's article sharing policy. Sharing preprints, such as on a preprint server, will not count as prior publication.We advise you to read our policy on multiple, redundant or concurrent publication. In support of Open Science, this journal offers its authors a free preprint posting service on SSRN, Elsevier’s preprint and early research …
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- W.B. Saunders Ltd
- Country or region
- ENGLAND
- Language
- English
- Frequency
- Monthly
- Founded
- 1989
- ISSN
- 0954-6111
- Electronic ISSN
- 1532-3064
- Official links
- Journal homepage ↗OpenAlex
- Submission system ↗Publisher website
- Special issues ↗Publisher website
FAQ
Frequently asked questions about Respiratory Medicine
What CAS zone is Respiratory Medicine in?
In the 2025 upgraded edition of the CAS Journal Ranking, Respiratory Medicine is in Zone 3 of Medicine, and in Zone 3 of the minor category Cardiac & Cardiovascular Systems / Respiratory System. In the 2026 Xinrui edition it is in Zone 3 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of Respiratory Medicine?
The latest impact factor listed by LetPub is 3.28; CiteScore 4.3, h-index 175.
How long does peer review take at Respiratory Medicine?
Based on the dates recorded on 117 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 128 days (interquartile range 91–171 days); authors report an average review time of about 3 months; the community-reported acceptance is “about 25%”. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
What are the manuscript requirements of Respiratory Medicine?
According to the journal's author guidelines: Abstract: ≤ 250 words; Keywords: 1–7; Manuscript length: ≤ 4,500 words; Reference style: Numbered, in order of citation. A model extracted these from the author guidelines and each was checked against the text; check the latest version on the journal's website before submitting.
Where are the editorial board members of Respiratory Medicine based?
Of the 106 board members whose country the journal's board page names, 2 (about 2%) are in mainland China; the countries named most often are United States (48), Italy (13) and United Kingdom (6). Counted from the institutions listed on the board page; for reference only.
Which databases index Respiratory Medicine?
According to LetPub and DOAJ records, Respiratory Medicine is indexed in SCIE and Scopus.
Is Respiratory Medicine open access, and what is the APC?
Respiratory Medicine is a hybrid journal. For open-access publication: APC about USD 3,630.
Sources and updates
The facts on this page come from LetPub, Publisher website, OpenAlex; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-26). Last updated: .